The Current Ratio as of December 2025 (TTM) for Yabao Pharmaceutical Group Co., Ltd (600351.SS) is 3.14

According to Yabao Pharmaceutical Group Co., Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 3.14. This represents a change of 8.86% compared to the average of 2.88 of the last 4 quarters.

Yabao Pharmaceutical Group Co., Ltd (600351.SS) Historical Current Ratio (quarterly & annually)

How has 600351.SS Current Ratio performed in the past?

The mean historical Current Ratio of Yabao Pharmaceutical Group Co., Ltd over the last ten years is 1.69. The current 3.14 Current Ratio has changed 18.42% with respect to the historical average. Over the past ten years (40 quarters), 600351.SS's Current Ratio was at its highest in in the September 2025 quarter at 3.14. The Current Ratio was at its lowest in in the December 2016 quarter at 1.20.

Yabao Pharmaceutical Group Co., Ltd (600351.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Yabao Pharmaceutical Group Co., Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Yabao Pharmaceutical Group Co., Ltd (600351.SS) Average Current Ratio

How has 600351.SS Current Ratio performed in the past?

The current Current Ratio of Yabao Pharmaceutical Group Co., Ltd (600351.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Yabao Pharmaceutical Group Co., Ltd (600351.SS) Current Ratio vs. Peers

How is 600351.SS’s Current Ratio compared to its peers?

Yabao Pharmaceutical Group Co., Ltd’s Current Ratio is less than Tibet Weixinkang Medicine Co., Ltd. (4.07), greater than ZhuZhou QianJin Pharmaceutical Co.,Ltd (1.40), greater than Jinhe Biotechnology Co. Ltd. (0.94), greater than Hunan Fangsheng Pharmaceutical Co., Ltd. (0.86), less than Wuhan Hiteck Biological Pharma Co.,Ltd (4.60), greater than LanZhou Foci Pharmaceutical Co.,Ltd. (3.10), greater than Zhejiang Starry Pharmaceutical Co.,Ltd. (0.89), less than Tianjin Lisheng Pharmaceutical Co.,Ltd. (4.62), greater than HPGC Renmintongtai Pharmaceutical Corporation (1.68), greater than Harbin Medisan Pharmaceutical Co., Ltd. (0.97),

Build a custom stock screener for Yabao Pharmaceutical Group Co., Ltd (600351.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Yabao Pharmaceutical Group Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Yabao Pharmaceutical Group Co., Ltd (600351.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Yabao Pharmaceutical Group Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.